Recombinant human thioredoxin suppresses lipopolysaccharide-induced bronchoalveolar neutrophil infiltration in rat
- 15 August 2006
- journal article
- Published by Elsevier in Life Sciences
- Vol. 79 (12) , 1170-1177
- https://doi.org/10.1016/j.lfs.2006.03.026
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Thioredoxin-1 Ameliorates Myosin-Induced Autoimmune Myocarditis by Suppressing Chemokine Expressions and Leukocyte Chemotaxis in MiceCirculation, 2004
- Intravenous Administration of Thioredoxin Decreases Brain Damage Following Transient Focal Cerebral Ischemia in MiceAntioxidants and Redox Signaling, 2004
- Overexpression of Thioredoxin Prevents Acute Hepatitis Caused by Thioacetamide or Lipopolysaccharide in MiceHepatology, 2003
- Neutrophils and acute lung injuryCritical Care Medicine, 2003
- Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicityOncogene, 2002
- The Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- REDOX REGULATION OF CELLULAR ACTIVATIONAnnual Review of Immunology, 1997
- Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity.Journal of Clinical Investigation, 1996
- Elevation of plasma thioredoxin levels in HIV-infected individualsInternational Immunology, 1996
- Endotoxin, reticuloendothelial function, and liver injuryHepatology, 1981